Actively Recruiting
Randomized Study of Mannan-Conjugated Allergoids EP-088MM09 Compared to Placebo for Treating House Dust Mite Allergic Rhinitis and Rhinoconjunctivitis
Led by Inmunotek S.L. · Updated on 2026-10-29
250
Participants Needed
16
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether EP-088MM09, which contains modified house dust mite allergens called mannan-conjugated allergoids, can treat house dust mite allergy and how safe it is. The trial involves people aged 12 to 65 years who have persistent moderate to severe nasal allergy symptoms, with or without eye symptoms, and may have mild to moderate controlled allergic asthma. The study compares EP-088MM09 with a placebo to see if it reduces allergy symptoms and the need for symptom-relief medicines. Participants are randomly assigned to receive either EP-088MM09 or a placebo, which looks the same but contains no active ingredients. The treatment includes 12 monthly visits with injections under the skin two injections at the first visit and one injection at each subsequent visit. Participants stay at the clinic for at least 30 minutes after each injection. Those sensitive to pollen may have an extra baseline visit to avoid pollen season influence. The study includes a screeningbaseline phase, treatment phase, and a final follow-up about one month after the last treatment. During the study, participants will keep daily records of their symptoms and medication use and complete questionnaires about their symptoms and quality of life. Blood samples will be collected at scheduled visits. Researchers will assess the combined symptom and medication score over multiple periods, including a main evaluation covering four weeks after treatment ends. Participants will be involved for about 14 to 21 months, with regular monitoring of health and treatment adherence throughout.
CONDITIONS
Brief Title
Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis. MM09-SIT-063.
Research Team
R
Raquel Caballero
M
Marta Romero
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here